Scilex Holding SCLX
NASDAQ SCLX
$5.73 -0.07 (-1.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Scilex Holding (SCLX) Other Accumulated Expenses (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Other Accumulated Expenses of $247.5 million for Q1 2026, up 46.95% year-over-year from $168.4 million in Q1 2025, and up 7485.47% quarter-over-quarter from $3.3 million in Q4 2025.

Scilex Holding (SCLX) Other Accumulated Expenses (2020 - 2026) Analysis & Trends

Scilex Holding's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $247.5 million for Q1 2026.

  • In Q1 2026, Other Accumulated Expenses rose 46.95% year-over-year to $247.5 million; the TTM figure through Mar 2026 stood at $247.5 million (up 46.95% YoY), while the FY2025 annual figure was $3.3 million, down 97.99% from the prior year.
  • Other Accumulated Expenses for Q1 2026 stood at $247.5 million, up from $3.3 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $247.5 million in Q1 2026, with the low at $3.3 million in Q4 2025.
  • The 5-year median for Other Accumulated Expenses is $114.6 million (2024), against an average of $116.3 million.
  • The sharpest annual moves came in 2022 and 2025: Other Accumulated Expenses surged 319.63% in 2022, then plunged 97.99% in 2025.
  • Scilex Holding's Other Accumulated Expenses stood at $30.9 million in 2022, then jumped by 190.22% to $89.7 million in 2023, then surged by 81.26% to $162.5 million in 2024, then slumped by 97.99% to $3.3 million in 2025, then jumped by 7485.47% to $247.5 million in 2026.
  • Business Quant data shows SCLX's Other Accumulated Expenses at $247.5 million in Q1 2026, $3.3 million in Q4 2025, and $213.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Scilex Holding 39.22 Mn -73.57 Mn 3.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 247.51 Mn
Dec 31, 2025 3.26 Mn
Sep 30, 2025 213.38 Mn
Jun 30, 2025 192.94 Mn
Mar 31, 2025 168.43 Mn
Dec 31, 2024 162.52 Mn
Sep 30, 2024 141.71 Mn
Jun 30, 2024 125.06 Mn
Mar 31, 2024 104.09 Mn
Dec 31, 2023 89.66 Mn
Sep 30, 2023 65.80 Mn
Jun 30, 2023 47.78 Mn
Mar 31, 2023 35.63 Mn
Dec 31, 2022 30.89 Mn
Dec 31, 2021 7.36 Mn
Dec 31, 2020 25,760.00